Craniofacial cavernous venous malformations: Percutaneous sclerotherapy with use of ethanolamine oleate

Young Ho Choi, Moon Hee Han, O-Ki Kwon, Sang Hoon Cha, Kee Hyun Chang

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

PURPOSE: To assess the efficacy of percutaneous sclerotherapy with use of ethanolamine oleate for craniofacial cavernous venous malformations. MATERIALS AND METHODS: From 1991 to 2001, sclerotherapy (average of two procedures per patient) was performed in 29 patients (mean age, 22 y; 10 male) with craniofacial venous malformations. Direct puncture venography was performed with use of water-soluble contrast media to delineate the extent of the lesions. CO 2 gas was used as contrast medium in addition to water-soluble contrast media in five patients in whom lesions had large nondependent areas. Coil embolization with a transvenous approach was performed in two patients when the lesions had large draining veins. Then, a mixture of 5% ethanolamine oleate and iodized oil (ratio, 5:1-5:2) was injected manually into the lesions under fluoroscopic guidance to monitor the process. A total of 59 procedures were performed. Clinical follow-up was obtained in 25 of 29 patients. The duration of follow-up ranged from 10 days to 6 years (mean, 8.5 mo). The effectiveness of sclerotherapy was assessed on the basis of clinical, surgical, and radiologic findings. RESULTS: The procedures were effective in 14 of 16 patients who underwent sclerotherapy only. The procedures were beneficial for all nine patients who underwent sclerotherapy and surgery. There was no skin injury or nerve damage. The trismus that appeared in two patients with lesions in the masticator space was treated well by conservative therapy. CONCLUSION: Percutaneous sclerotherapy with use of ethanolamine oleate is a safe and effective treatment of craniofacial cavernous venous malformations. However, renal function was not specifically evaluated after treatment, and therefore occult renal dysfunction cannot be excluded.

Original languageEnglish
Pages (from-to)475-482
Number of pages8
JournalJournal of Vascular and Interventional Radiology
Volume13
Issue number5
DOIs
StatePublished - 1 Jan 2002

Fingerprint

Sclerotherapy
Contrast Media
Trismus
Ethiodized Oil
Kidney
ethanolamine oleate
Water
Phlebography
Carbon Monoxide
Punctures
Veins
Gases
Skin
Wounds and Injuries
Therapeutics

Keywords

  • Sclerotherapy
  • Venous malformations, craniofacial

Cite this

@article{38fd97b6d5cb478a9d338e9222c4c260,
title = "Craniofacial cavernous venous malformations: Percutaneous sclerotherapy with use of ethanolamine oleate",
abstract = "PURPOSE: To assess the efficacy of percutaneous sclerotherapy with use of ethanolamine oleate for craniofacial cavernous venous malformations. MATERIALS AND METHODS: From 1991 to 2001, sclerotherapy (average of two procedures per patient) was performed in 29 patients (mean age, 22 y; 10 male) with craniofacial venous malformations. Direct puncture venography was performed with use of water-soluble contrast media to delineate the extent of the lesions. CO 2 gas was used as contrast medium in addition to water-soluble contrast media in five patients in whom lesions had large nondependent areas. Coil embolization with a transvenous approach was performed in two patients when the lesions had large draining veins. Then, a mixture of 5{\%} ethanolamine oleate and iodized oil (ratio, 5:1-5:2) was injected manually into the lesions under fluoroscopic guidance to monitor the process. A total of 59 procedures were performed. Clinical follow-up was obtained in 25 of 29 patients. The duration of follow-up ranged from 10 days to 6 years (mean, 8.5 mo). The effectiveness of sclerotherapy was assessed on the basis of clinical, surgical, and radiologic findings. RESULTS: The procedures were effective in 14 of 16 patients who underwent sclerotherapy only. The procedures were beneficial for all nine patients who underwent sclerotherapy and surgery. There was no skin injury or nerve damage. The trismus that appeared in two patients with lesions in the masticator space was treated well by conservative therapy. CONCLUSION: Percutaneous sclerotherapy with use of ethanolamine oleate is a safe and effective treatment of craniofacial cavernous venous malformations. However, renal function was not specifically evaluated after treatment, and therefore occult renal dysfunction cannot be excluded.",
keywords = "Sclerotherapy, Venous malformations, craniofacial",
author = "Choi, {Young Ho} and Han, {Moon Hee} and O-Ki Kwon and Cha, {Sang Hoon} and Chang, {Kee Hyun}",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S1051-0443(07)61527-9",
language = "English",
volume = "13",
pages = "475--482",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "5",

}

Craniofacial cavernous venous malformations : Percutaneous sclerotherapy with use of ethanolamine oleate. / Choi, Young Ho; Han, Moon Hee; Kwon, O-Ki; Cha, Sang Hoon; Chang, Kee Hyun.

In: Journal of Vascular and Interventional Radiology, Vol. 13, No. 5, 01.01.2002, p. 475-482.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Craniofacial cavernous venous malformations

T2 - Percutaneous sclerotherapy with use of ethanolamine oleate

AU - Choi, Young Ho

AU - Han, Moon Hee

AU - Kwon, O-Ki

AU - Cha, Sang Hoon

AU - Chang, Kee Hyun

PY - 2002/1/1

Y1 - 2002/1/1

N2 - PURPOSE: To assess the efficacy of percutaneous sclerotherapy with use of ethanolamine oleate for craniofacial cavernous venous malformations. MATERIALS AND METHODS: From 1991 to 2001, sclerotherapy (average of two procedures per patient) was performed in 29 patients (mean age, 22 y; 10 male) with craniofacial venous malformations. Direct puncture venography was performed with use of water-soluble contrast media to delineate the extent of the lesions. CO 2 gas was used as contrast medium in addition to water-soluble contrast media in five patients in whom lesions had large nondependent areas. Coil embolization with a transvenous approach was performed in two patients when the lesions had large draining veins. Then, a mixture of 5% ethanolamine oleate and iodized oil (ratio, 5:1-5:2) was injected manually into the lesions under fluoroscopic guidance to monitor the process. A total of 59 procedures were performed. Clinical follow-up was obtained in 25 of 29 patients. The duration of follow-up ranged from 10 days to 6 years (mean, 8.5 mo). The effectiveness of sclerotherapy was assessed on the basis of clinical, surgical, and radiologic findings. RESULTS: The procedures were effective in 14 of 16 patients who underwent sclerotherapy only. The procedures were beneficial for all nine patients who underwent sclerotherapy and surgery. There was no skin injury or nerve damage. The trismus that appeared in two patients with lesions in the masticator space was treated well by conservative therapy. CONCLUSION: Percutaneous sclerotherapy with use of ethanolamine oleate is a safe and effective treatment of craniofacial cavernous venous malformations. However, renal function was not specifically evaluated after treatment, and therefore occult renal dysfunction cannot be excluded.

AB - PURPOSE: To assess the efficacy of percutaneous sclerotherapy with use of ethanolamine oleate for craniofacial cavernous venous malformations. MATERIALS AND METHODS: From 1991 to 2001, sclerotherapy (average of two procedures per patient) was performed in 29 patients (mean age, 22 y; 10 male) with craniofacial venous malformations. Direct puncture venography was performed with use of water-soluble contrast media to delineate the extent of the lesions. CO 2 gas was used as contrast medium in addition to water-soluble contrast media in five patients in whom lesions had large nondependent areas. Coil embolization with a transvenous approach was performed in two patients when the lesions had large draining veins. Then, a mixture of 5% ethanolamine oleate and iodized oil (ratio, 5:1-5:2) was injected manually into the lesions under fluoroscopic guidance to monitor the process. A total of 59 procedures were performed. Clinical follow-up was obtained in 25 of 29 patients. The duration of follow-up ranged from 10 days to 6 years (mean, 8.5 mo). The effectiveness of sclerotherapy was assessed on the basis of clinical, surgical, and radiologic findings. RESULTS: The procedures were effective in 14 of 16 patients who underwent sclerotherapy only. The procedures were beneficial for all nine patients who underwent sclerotherapy and surgery. There was no skin injury or nerve damage. The trismus that appeared in two patients with lesions in the masticator space was treated well by conservative therapy. CONCLUSION: Percutaneous sclerotherapy with use of ethanolamine oleate is a safe and effective treatment of craniofacial cavernous venous malformations. However, renal function was not specifically evaluated after treatment, and therefore occult renal dysfunction cannot be excluded.

KW - Sclerotherapy

KW - Venous malformations, craniofacial

UR - http://www.scopus.com/inward/record.url?scp=0036096080&partnerID=8YFLogxK

U2 - 10.1016/S1051-0443(07)61527-9

DO - 10.1016/S1051-0443(07)61527-9

M3 - Article

C2 - 11997355

AN - SCOPUS:0036096080

VL - 13

SP - 475

EP - 482

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 5

ER -